Drug Type Small molecule drug |
Synonyms Pibutidine, Pibutidine hydrochloride (JAN), 哌布替丁 + [2] |
Target |
Action antagonists |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H25ClN4O3 |
InChIKeyODBOENMSSFCACZ-PVOKDAACSA-N |
CAS Registry126463-66-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01861 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Duodenal Ulcer | Phase 3 | Japan | - | - |
Duodenal Ulcer | Phase 3 | - | - | |
Duodenal Ulcer | Phase 3 | - | - | |
Peptic Ulcer | Preclinical | Japan | 01 Jan 1990 |